An update on breast cancer screening and prevention.
The goal of this article is to provide clinical guidance on breast cancer screening and prevention in primary care. The discussion highlights the importance of risk assessment, including screening options and risk-reduction strategies, for women at average and high risk. We review recommendations for breast cancer screening, evaluate current evidence on primary prevention, examine current practice patterns, and consider the impact of recent changes within health care.
Department of Family and Community Medicine, Thomas Jefferson University, 833 Chestnut Street, Suite 301, Philadelphia, PA 19107, USA. Electronic address: MariaSyl.delaCruz@jefferson.edu.
Maria Syl D
MS
de la Cruz
Department of Family and Community Medicine, Thomas Jefferson University, 833 Chestnut Street, Suite 301, Philadelphia, PA 19107, USA.
Mona
M
Sarfaty
Department of Family and Community Medicine, Thomas Jefferson University, 833 Chestnut Street, Suite 301, Philadelphia, PA 19107, USA; American Cancer Society, 250 Williams Street, Atlanta, GA 30303, USA.
Richard C
RC
Wender
D000328:Adult; D000367:Age Factors; D000368:Aged; D000428:Alcohol Drinking / Q000453:epidemiology; D015992:Body Mass Index; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000453:epidemiology*; D004032:Diet; D055088:Early Detection of Cancer / Q000379:methods*; D015444:Exercise; D005260:Female; D020022:Genetic Predisposition to Disease; D015438:Health Behavior; D006297:Health Services Accessibility; D006801:Humans; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000458:organization & administration*; D018570:Risk Assessment; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage; D012907:Smoking / Q000453:epidemiology
D020845:Selective Estrogen Receptor Modulators
Breast MRI; Breast cancer prevention; Breast cancer risk assessment; Breast cancer screening; Guidelines; Mammography